glp-1 cirrhosis GI and Hepatology News GLP-1s May Protect Against Progression

10.1155/2020/8840675 Neural Plast

By losing weight, it makes being more active and exercising more frequently much easier

While GLP-1 agonists have been shown to have central nervous system action, another possible mechanism is slowed gastric emptying 32,33,34 , which could increase fullness and reduce alcohol consumption

The absence of TQT data is a gap, not evidence of safety

Heres a quick look at the most common side effects for each medication, as reported by at least 5% of people in clinical trials: For some people, these side effects can become disruptive, leading them to seek an alternative medication

Verify the current FDA approval status before any research planning by checking the FDA website and ClinicalTrials.gov for the most recent CagriSema and cagrilintide entries